Clinical Trial Update: Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effectiveness of narrow-band ultraviolet B therapy combined with topical tacrolimus 0.03% in vitiligo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Narrow-band ultraviolet B
• Tacrolimus 0.03% (tacrolimus)

Snippet

Sponsor: South Valley University | Conditions: Vitiligo | Phase 4 | Status: UNKNOWN